Quality Services • CAP & CLIA Accredited
seniors wellness care logo
seniors wellness care name
Genetic Testing & Molecular Diagnostics
Endocrine Health • Nodule & Autoimmune AnalysisPANEL-THY-14

Thyroid & Endocrine Health Panel

The Thyroid and Endocrine Panel provides vital genetic insights into both neoplastic risks (such as familial Medullary Thyroid Carcinoma) and inherited autoimmune pathways underlying Hashimoto’s disease and Graves’ ophthalmopathy. Accurate profiling empowers physicians to personalize surveillance and hormone balance protocols.

Endocrine Genes14 Targets
Medicare Part B100% Covered
Turnaround7–10 Days
SampleBuccal Swab

Check If You Qualify

Takes under 2 minutes • Quick Pre-Qualification

Check Eligibility →
HIPAA 256-Bit Encrypted

Who Should Consider This Screening?

Healthcare providers recommend this diagnostic panel for individuals with the following personal or family health indicators:

Personal diagnosis or family history of medullary thyroid cancer or pheochromocytoma.
Unexplained elevated serum calcitonin or parathyroid hormone (PTH) levels.
Multiple family members with refractory thyroid nodules, goiter, or autoimmune thyroid disorders.
Clinical signs of Multiple Endocrine Neoplasia (hypercalcemia, pituitary tumors).

Biomarkers & Genes Evaluated in this Panel

Processed using high-complexity Next-Generation Sequencing (NGS) in CLIA-certified and CAP-accredited partner laboratories.

Gene Symbol / NameClinical SignificanceActionable Impact
RETProto-Oncogene Tyrosine Kinase ReceptorThe definitive genetic driver of Multiple Endocrine Neoplasia Type 2 (MEN2) and familial Medullary Thyroid Cancer.Guides life-saving prophylactic surgical timing, calcitonin monitoring, and targeted RET kinase inhibitor therapy.
MEN1Menin Tumor SuppressorRegulates parathyroid, anterior pituitary, and pancreatic neuroendocrine cell proliferation.Directs annual calcium/PTH blood testing and specialized endocrine MRI surveillance.
TSHR & TGThyrotropin Receptor & ThyroglobulinGoverns thyroid hormone synthesis, congenital dyshormonogenesis, and autoimmune receptor reactivity.Assists endocrinologists in fine-tuning synthetic levothyroxine / T3 combination dosing protocols.

Sample Report & Diagnostic Action Plan

Every patient receives an easy-to-understand diagnostic summary and a detailed clinical report tailored for their primary care doctor.

Sample Result ClassificationNegative / Standard Baseline
Identified Finding:

No pathogenic variants detected in RET, MEN1, or primary endocrine malignancy loci.

Clinician Recommendation:

Routine annual TSH/Free T4 monitoring with primary care physician; standard thyroid ultrasound management as clinically indicated.

Clinical Care & Laboratory Standards

How our licensed physician network and accredited laboratories deliver personalized diagnostic clarity to your doorstep:

100% Physician-Ordered & CLIA Lab Certified

Physician-ordered endocrine genomic profiling analyzes RET, MEN1, and hormone synthesis loci to evaluate thyroid nodule risks, hereditary neoplasms, and autoimmune pathways.

Our network of state-licensed physicians reviews your clinical indications to confirm medical necessity and coordinate care before any kit is mailed.
Physician-Ordered Clinical Screening

Ready to Check Your Eligibility for Thyroid & Endocrine Health Panel?

Takes under 2 minutes • Painless at-home cheek swab • 100% Physician Reviewed

Start 2-Minute Pre-Qualification →